Type Here
Media and Research
prev
ALL Parkinson’s Pain and inflammation BRAIN HEALTH GUT HEALTH Media and Research
next
EXPLORE ARTICLES
SYMBYX Announces Its Selection by Newcastle University, UK, to Support a Major Clinical Trial Testing the Effects of Light Therapy on Parkinson’s Symptoms.

SYMBYX Announces Its Selection by Newcastle Uni...

Media and Research

SYMBYX Announces Its Selection by Newcastle Uni...

Read More
SYMBYX and University of Leeds announce ground-breaking study to explain mechanistic basis of light therapy for improving gut health

SYMBYX and University of Leeds announce ground-...

Media and Research

SYMBYX and University of Leeds announce ground-...

Read More
MEDIA RELEASE—SYMBYX Neuro Helmet Shows Promise in Parkinson’s: SAN Trial Highlights

MEDIA RELEASE—SYMBYX Neuro Helmet Shows Promise...

Media and Research

MEDIA RELEASE—SYMBYX Neuro Helmet Shows Promise...

Read More
What is light therapy?

What is light therapy?

Media and Research

What is light therapy?

Read More
5 years of continued light therapy use for Parkinson's - trial results now published

5 years of continued light therapy use for Park...

Media and Research

5 years of continued light therapy use for Park...

Read More
7 NEWS | Infra-red helmet with light waves delivers hope for Australians with Parkinson's disease

7 NEWS | Infra-red helmet with light waves deli...

Media and Research

7 NEWS | Infra-red helmet with light waves deli...

Read More
WEBINARS
prev
No Silver Bullet

NSB4PD interview Wayne Markman on SYMBYX light therapy and upcoming research pipeline.

Larry Gifford

PD Avengers' Larry Gifford speaks to SYMBYX about how to be your own Parkinson's Advocate.

When life gives you Parkinson's

Rebecca and Larry Gifford interview Orla Hares and Wayne Markman on the clinical trial underway in Ontario and SYMBYX light therapy.

next
SYMBYX IN THE MEDIA

11/01/23

Parkinson's News Today

Gains Seen in Parkinson's with Symbyx's Red Light Therapy Helmet. Symbyx Neuro uses a 12-minute cycle of red light therapy followed by 12 minutes of infrared light therapy. Improvement was seen across measures of facial expression, upper limb, walking, and tremor.

Read More
PRESS RELEASES
prev
SYMBYX Announces Its Selection by Newcastle University, UK, to Support a Major Clinical Trial Testing the Effects of Light Therapy on Parkinson’s Symptoms.
SYMBYX Biome

SYMBYX Announces Its Selection by Newcastle University, UK, to Support a Major Clinical Trial Testing the Effects of Light Therapy on Parkinson’s Symptoms.

Read More
SYMBYX and University of Leeds announce ground-breaking study to explain mechanistic basis of light therapy for improving gut health
SYMBYX Biome

SYMBYX and University of Leeds announce ground-breaking study to explain mechanistic basis of light therapy for improving gut health

Read More
SYMBYX announces promising SAN clinical trial results for Parkinson’s using the SYMBYX Neuro - the new red light therapy helmet
SYMBYX Biome

SYMBYX announces promising SAN clinical trial results for Parkinson’s using the SYMBYX Neuro - the new red light therapy helmet

Read More
SYMBYX light therapy in 5 abstracts presented at the World Parkinson's Congress 2023
SYMBYX Biome

SYMBYX light therapy in 5 abstracts presented at the World Parkinson's Congress 2023

Read More
TWO NEW CLINICAL TRIALS
SYMBYX Biome

TWO NEW CLINICAL TRIALS

Read More
Mater Research leads world-first trial for bowel disease
SYMBYX Biome

Mater Research leads world-first trial for bowel disease

Read More
SYMBYX announces start of ground-breaking Parkinson’s light therapy trial in Canada
SYMBYX Biome

SYMBYX announces start of ground-breaking Parkinson’s light therapy trial in Canada

Read More
SYMBYX company closes A-Round funding, May 2021
SYMBYX Biome

SYMBYX company closes A-Round funding, May 2021

Read More
next

Let's Connect

Join our growing facebook community group; share your experiences, ask questions, and connect with people using SYMBYX devices

Join today